Acute Effects of Focused Ultrasound-Induced Blood-Brain Barrier Opening on Anti-Pyroglu3 Abeta Antibody Delivery and Immune Responses

Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid plaques and hyperphosphorylated tau in the brain. Currently, therapeutic agents targeting amyloid appear promising for AD, however, delivery to the CNS is limited due to the blood-brain-barrier (BBB...

Descripción completa

Detalles Bibliográficos
Autores principales: Bathini, Praveen, Sun, Tao, Schenk, Mathias, Schilling, Stephan, McDannold, Nathan J., Lemere, Cynthia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313174/
https://www.ncbi.nlm.nih.gov/pubmed/35883506
http://dx.doi.org/10.3390/biom12070951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313174/
https://www.ncbi.nlm.nih.gov/pubmed/35883506
http://dx.doi.org/10.3390/biom12070951

Ejemplares similares